FOXP3 and breast cancer: Paired analyses of pre‐ and post‐NAC samples demonstrated higher levels of CD3 + CD8 + FOXP3‐lymphocytes in residual luminal and triple‐negative BC and higher levels of CD3 + CD8‐FOXP3‐lymphocytes in residual triple‐negative BC compared with other subtypes of lymphocytes.